Media Materials

Fast Facts

  • Founded in 2006, Tolmar is a fully integrated pharmaceutical company focused on the development, approval and commercialization of specialty pharmaceutical products across the therapeutic areas of urology, oncology and dermatology.
  • Tolmar is a privately held company. “Tolmar” refers to Tolmar Holdings, Inc. and its wholly owned operating subsidiaries, Tolmar, Inc. (product development and manufacturing), Tolmar Therapeutics, Inc. (licensing), and Tolmar Pharmaceuticals, Inc. (sales and marketing).
  • Tolmar has a commercial presence across urology, oncology, and hospital settings across the United States , with commercial headquarters in Lincolnshire, Illinois. Tolmar’s development, regulatory and production facilities, occupying more than 340,000 square feet, are based in Fort Collins, Colorado, with additional facilities located in Windsor, Colorado.
    • Our Colorado-based capabilities include:
      • Chemistry and microbiology laboratories
      • Multi-shift production operations
      • cGMP-compliant manufacturing
      • Semisolid, lyophilization, and injectable filling lines
      • Warehouse and cold-chain distribution
  • Tolmar has earned a reputation for our unique delivery technologies and formulation capabilities, including specialty injectables and prescription topical ointments, creams, gels and lotions for dermatologic applications.
  • Our specialty generic products are sold by leading pharmaceutical companies, and we maintain a robust pipeline of additional development stage candidates.
  • Tolmar is the innovator, developer and global manufacturer for ELIGARD®, (leuprolide acetate for injectable suspension), which is distributed worldwide.
  • Tolmar has more than 700 employees across the U.S.
  • We have 22 marketed products, supported by 5 New Drug Applications (NDAs) and 17 Abbreviated New Drug Applications (ANDAs).

For media inquiries, or if you are a reporter looking for more information about Tolmar and would like to reach a spokesperson, please contact:

Julie Ferguson
JFPR MediaGroup
(312) 385-0098